GHRS
NASDAQ · Pharmaceuticals
Gh Research Plc
$21.08
+0.07 (+0.33%)
Open$21.08
Previous Close$21.01
Day High$21.44
Day Low$20.75
52W High$24.66
52W Low$9.46
Volume—
Avg Volume210.6K
Market Cap1.44B
P/E Ratio—
EPS$-0.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+128.8% upside
Current
$21.08
$21.08
Target
$48.23
$48.23
$34.28
$48.23 avg
$66.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 289.57M | 263.52M | 305.92M |
| Net Income | 46.13M | 45.80M | 47.46M |
| Profit Margin | 15.9% | 17.4% | 15.5% |
| EBITDA | 85.32M | 72.54M | 88.44M |
| Free Cash Flow | 28.26M | 23.23M | 28.03M |
| Rev Growth | +11.0% | +19.2% | +2.7% |
| Debt/Equity | 0.68 | 0.55 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |